EffPha at the BIO Asia- Taiwan 2023 International Conference & Exhibition Was a Complete Success

Efficient Pharma Management Corp. (EffPha) was present at the BIO Asia- Taiwan 2023 International Conference & Exhibition as a full-service CRO, providing one-stop clinical trial services, including regulatory strategic and application services, clinical study design, and clinical study management and monitoring services.

EffPha has a team of Scientific Directors with more than 30 years of experience in global drug development, team of senior Scientists who have designed numerous clinical study protocols with extensive experience in regulatory affairs, as well as our Clinical Operation team with over 25 years of experience in clinical management and monitoring, interacting with clients and providing consulting discussions on clients’ drug development projects at our booth during the exhibition. We have received praise and trust from the clients, demonstrating EffPha team's experience and capabilities in drug development.
 
Throughout the exhibition, a number of experts in industry visited our booth to inquire about EffPha’s one-stop clinical trial services. The four-day exhibition came to an end with fruitful interactions with both new and existing clients. EffPha is familiar with the drug regulations and review application processes in Taiwan and US, and maintains good relationships and interactions with regulatory authorities. We have achieved a 100% IND submission approval rate for our clients so far, which is attributed to EffPha team's experience and expertise, as well as our efficient project delivery in meeting clients’ needs. EffPha will continue to strive to provide efficient and high-quality services, aiming to maximize the value of clients' drug development projects.
 
EffPha is committed to supporting the development journey of clients’ drugs with the most professional and highest quality services, and looks forward to meeting everyone again in the future!